Literature DB >> 18677587

[Hypertension and overweight].

Jörg Slany1.   

Abstract

Obesity shows a strong association with hypertension, primarily due to secretion of an abundance of para- and endocrine peptides by the visceral adipose tissue that play a key role in the pathogenesis of high blood pressure and are responsible for the accelerated atherothrombosis encountered in overweight individuals. Increased activity of the RAAS and the sympathetic nerve system are the main pathophysiologic factors; hypertension in obese subjects is characterized by increased peripheral arterial resistance, high cardiac output, hypervolemia and salt sensitivity. Medical therapy sees blockade of the RAAS in front. Priority in treatment should be given to improvements in life style, primarily in increasing physical activity and decreasing caloric intake, and to medical treatment of associated risk factors according to the modern concept of global risk management.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18677587     DOI: 10.1007/s10354-008-0560-9

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  11 in total

Review 1.  Diagnosis and management of hypertension in obesity.

Authors:  K Narkiewicz
Journal:  Obes Rev       Date:  2006-05       Impact factor: 9.213

2.  Increased blood pressure reactivity to dietary salt in patients with the metabolic syndrome.

Authors:  I S Hoffmann; L X Cubeddu
Journal:  J Hum Hypertens       Date:  2007-02-01       Impact factor: 3.012

3.  High prevalence of unrecognized sleep apnoea in drug-resistant hypertension.

Authors:  A G Logan; S M Perlikowski; A Mente; A Tisler; R Tkacova; M Niroumand; R S Leung; T D Bradley
Journal:  J Hypertens       Date:  2001-12       Impact factor: 4.844

Review 4.  Regional adiposity and morbidity.

Authors:  A H Kissebah; G R Krakower
Journal:  Physiol Rev       Date:  1994-10       Impact factor: 37.312

5.  Influence of Sibutramine on blood pressure: evidence from placebo-controlled trials.

Authors:  J Jordan; J Scholze; B Matiba; A Wirth; H Hauner; A M Sharma
Journal:  Int J Obes (Lond)       Date:  2005-05       Impact factor: 5.095

6.  Changes in metabolic syndrome variables since childhood in prehypertensive and hypertensive subjects: the Bogalusa Heart Study.

Authors:  Sathanur R Srinivasan; Leann Myers; Gerald S Berenson
Journal:  Hypertension       Date:  2006-06-12       Impact factor: 10.190

7.  Blood pressure levels and obesity trends in hypertensive and normotensive Finnish population from 1982 to 1997.

Authors:  M J Kastarinen; A M Nissinen; E A Vartiainen; P J Jousilahti; H J Korhonen; P M Puska
Journal:  J Hypertens       Date:  2000-03       Impact factor: 4.844

8.  Weight loss and the renin-angiotensin-aldosterone system.

Authors:  Stefan Engeli; Jana Böhnke; Kerstin Gorzelniak; Jürgen Janke; Petra Schling; Michael Bader; Friedrich C Luft; Arya M Sharma
Journal:  Hypertension       Date:  2005-01-03       Impact factor: 10.190

9.  The association of waist circumference with ambulatory blood pressure is independent of alternative adiposity indices.

Authors:  Olebogeng H I Majane; Gavin R Norton; Muzi J Maseko; Siyanda Makaula; Nigel Crowther; Janice Paiker; Lutgarde Thijs; Richard Brooksbank; Pinhas Sareli; Jan A Staessen; Angela J Woodiwiss
Journal:  J Hypertens       Date:  2007-09       Impact factor: 4.844

10.  Body weight changes with beta-blocker use: results from GEMINI.

Authors:  Franz H Messerli; David S H Bell; Vivian Fonseca; Richard E Katholi; Janet B McGill; Robert A Phillips; Philip Raskin; Jackson T Wright; Sripal Bangalore; Fred K Holdbrook; Mary Ann Lukas; Karen M Anderson; George L Bakris
Journal:  Am J Med       Date:  2007-07       Impact factor: 4.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.